share_log

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga ·  Mar 17, 2023 09:07

Gainers

  • Enzo Biochem (NYSE:ENZ) shares moved upwards by 79.8% to $2.14 during Friday's pre-market session. The market value of their outstanding shares is at $104.2 million.
  • MiNK Therapeutics (NASDAQ:INKT) shares rose 62.74% to $3.32. The company's market cap stands at $112.1 million.
  • Histogen (NASDAQ:HSTO) stock moved upwards by 29.88% to $1.12. The market value of their outstanding shares is at $4.7 million.
  • SQZ Biotechnologies (NYSE:SQZ) stock moved upwards by 20.33% to $0.71. The company's market cap stands at $20.9 million.
  • Lucy Scientific Discovery (NASDAQ:LSDI) stock rose 16.66% to $1.4. The company's market cap stands at $22.7 million.
  • Procaps Gr (NASDAQ:PROC) shares increased by 16.54% to $4.79. The market value of their outstanding shares is at $540.4 million.

Losers

  • Acer Therapeutics (NASDAQ:ACER) shares fell 47.8% to $0.81 during Friday's pre-market session. The company's market cap stands at $17.0 million.
  • Sarepta Therapeutics (NASDAQ:SRPT) stock declined by 19.66% to $120.25. The company's market cap stands at $10.5 billion.
  • Leap Therapeutics (NASDAQ:LPTX) shares decreased by 17.81% to $0.36. The market value of their outstanding shares is at $35.6 million.
  • ThermoGenesis Holdings (NASDAQ:THMO) stock decreased by 17.34% to $4.96. The company's market cap stands at $5.1 million.
  • Addex Therapeutics (NASDAQ:ADXN) shares declined by 13.59% to $1.05. The company's market cap stands at $20.1 million. As per the news, the Q4 earnings report came out 4 days ago.
  • Biophytis (NASDAQ:BPTS) stock declined by 12.55% to $0.48. The market value of their outstanding shares is at $9.8 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment